BioAtla BCAB
OTC BCAB
$1.60 +0.32 (+25.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

BioAtla (BCAB) Revenue (2020 - 2026)

Updated

BioAtla's Revenue came in at $6.5 million for Q2 2026.

Analysis

BioAtla (BCAB) Revenue (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported Revenue of $8.5 million, down 22.7% year-over-year; for FY2025, it came in at $2 million, down 81.8% from FY2024.

  • Revenue carries a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
  • Going back by year, Revenue was $11 million in FY2024 and $250,000 in FY2021 (-41.7%).
  • The Q2 2026 figure represents the highest quarterly Revenue since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 BioAtla 2.66 Mn 2.66 Mn - 6.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.50 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2024 11.00 Mn
Jun 30, 2021 250,000.00
Sep 30, 2020 150,000.00
Jun 30, 2020 190,000.00
Mar 31, 2020 89,000.00
API Access

BioAtla Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BCAB&period=max&api_key=YOUR_API_KEY